Kopp Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,427
Closed -$323K 59
2019
Q1
$323K Sell
3,427
-83
-2% -$7.26K 0.26% 46
2018
Q4
$225K Sell
3,510
-293
-8% -$21.6K 0.22% 59
2018
Q3
$340K Sell
3,803
-178
-4% -$15.7K 0.29% 47
2018
Q2
$316K Sell
3,981
-1,225
-24% -$102K 0.3% 50
2018
Q1
$464K Sell
5,206
-166
-3% -$15.9K 0.47% 52
2017
Q4
$561K Buy
5,372
+3,423
+176% +$386K 0.56% 49
2017
Q3
$284K Buy
+1,949
New +$265K 0.26% 56

Other funds holding CELG

Kopp Investment Advisors's CELG Position: Q2 2019 in Review

Kopp Investment Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 3,427 shares — an estimated $323K sold.

Kopp Investment Advisors first reported a position in CELG in Q3 2017 and held it in 7 quarters. The position peaked at $561K in Q4 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Kopp Investment Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Kopp Investment Advisors sold 3,427 Celgene Corp shares in Q2 2019, an estimated $323K.
  • Kopp Investment Advisors first reported a position in Celgene Corp in Q3 2017 and held it in 7 quarters.
  • Kopp Investment Advisors's Celgene Corp position peaked at $561K in Q4 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Kopp Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.